Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

27.50
Delayed Data
As of Jul 22
 +0.18 / +0.66%
Today’s Change
20.07
Today|||52-Week Range
39.17
-2.79%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close27.32
Today’s open27.26
Day’s range27.14 - 27.69
Volume150,264
Average volume (3 months)298,240
Market cap$925.1M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+67.86%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio114.9
Price/Sales11.37
Price/Book7.38

Competitors

 Today’s
change
Today’s
% change
FWPForward Pharma A/S+0.40+2.00%
ADROAduro Biotech Inc+0.33+2.41%
CLLSCellectis SA+0.07+0.28%
MGNXMacroGenics Inc+0.23+0.80%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs